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Organogenesis and Tumorigenesis: Insight From
the JAK/STAT Pathway in the Drosophila Eye
Ying-Hsuan Wang and Min-Lang Huang*
The Janus kinase (JAK) signal transducer and activator of transcription (STAT) pathway is one of the
main signaling pathways in eukaryotic cells. This pathway is used during diverse growth and develop-
mental processes in multiple tissues to control cell proliferation, differentiation, survival, and apoptosis.
In addition to its role during development, the JAK/STAT pathway has also been implicated in tumorigen-
esis. Drosophila melanogaster is a powerful genetic tool, and its eyes have been used extensively as a plat-
form to study signaling pathways. Many reports have demonstrated that the JAK/STAT pathway plays
pleiotropic roles in Drosophila eye development. Its functions and activation are decided by its interplay
with other signal pathways and the epigenetic status. In this review, we focus on the functions and regu-
lation of the JAK/STAT pathway during eye development and provide some insights into the study of this
pathway in tumorigenesis. Developmental Dynamics 239:2522–2533, 2010. V C 2010 Wiley-Liss, Inc.
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INTRODUCTION
Organogenesis is controlled by multi-
ple processes such as cell growth, pro-
liferation, and differentiation. These
processes need to be regulated coor-
dinately by complex networks of signal
pathways, without which organs
develop abnormally. The Janus kinase
(JAK) signal transducer and activator
of transcription (STAT) pathway is one
of the main signaling pathways in
eukaryotic cells. This pathway was
ﬁrst identiﬁed in interferon systems
and responses to a wide range of cyto-
kines and growth factors (Levy and
Darnell, 2002). The JAK/STAT path-
way is used to control cell prolifera-
tion, differentiation, survival, and
apoptosis during diverse growth and
developmental processes in multiple
tissues (Nosaka et al., 1999; Williams,
2000; Tsai and Sun, 2004; Stephanou
and Latchman, 2005). This pathway
also plays a crucial role in tumorigene-
sis (Calo et al., 2003; Smirnova et al.,
2007).
In general, activation of the JAK/
STAT pathway entails the binding of
an extracellular ligand to a transmem-
brane receptor, which causes the acti-
vation of the receptor-associated
JAKs. These tyrosine kinases then
phosphorylate themselves and their
associated receptors to provide dock-
ing sites for the STAT transcription
factors. After activation by the recep-
tor-JAK complex, STATs translocate
tothenucleusandregulatetheexpres-
sion of target genes. In mammals,
wide and diverse types of extracellular
ligands and transmembrane recep-
tors, and many subtypes of both JAKs
and STATs, are involved in the JAK/
STATpathway (Kisselevaetal.,2002).
Drosophila is a powerful genetic
tool. The components of the pathway
in Drosophila are relatively simple. It
is composed of a single ligand family
encoded by unpaired (upd) and upd-
like genes (Harrison et al., 1998; Bou-
lay et al., 2003), the receptor by dome-
less (dome; Brown et al., 2001), JAK by
hopscotch (hop; Binari and Perrimon,
1994), and STAT by Stat92E (Hou
et al., 1996; Yan et al., 1996). Because
ofthesimplicity ofthepathwayin Dro-
sophila, it provides a good platform for
studying the pathway. The JAK/STAT
pathway in Drosophila is implicated
in segmentation, eye development,
immune response, sex determination,
germ/stem cell development, and het-
erochromatin stability (Hombria and
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2006; Li, 2008). In recent years, the
Drosophila compound eye has been
used extensively as a model system to
study the functions of the JAK/STAT
pathway during several cell events
and tumorigenesis. Therefore, in this
review, we focus on the study of the
JAK/STAT pathway in Drosophila eye
development and provide cues for fur-
ther investigationsof this pathway.
THE JAK/STAT PATHWAY IN
DROSOPHILA
The JAK/STAT pathway in Drosophila
was originally identiﬁed by means of
its function in embryonic segmenta-
tion (Binari and Perrimon, 1994). Sim-
ilar to what is observed in mammals,
the pathway in Drosophila is com-
posed of four major factors: the
secreted ligand, the transmembrane
receptor, the JAK kinase, and the
STAT transcription factor (Hou et al.,
2002). Compared with various differ-
ent ligands (e.g., cytokines, interleu-
kin, and growth factors) that trigger
signaling in mammals (Subramaniam
et al., 2001; Langer et al., 2004), the
Upd and Upd-like proteins belong to
the only ligand family that activates
the JAK/STAT pathway in Drosophila
(Boulay et al., 2003). Upd was ﬁrst
identiﬁed as a ligand for the JAK/
STAT pathway; however, it is not
homologous to any known mammalian
cytokine or growth factor (Harrison
et al., 1998). Originally, the Unpaired-
like proteins, Upd2 and Upd3, were
predicted proteins; subsequently, they
were validated as ligands for the JAK/
STAT pathway (Harrison et al., 1998;
Hombria and Brown, 2002; Agaisse
et al., 2003; Gilbert et al., 2005). In
addition, the Drosophila genes dome-
less (dome), hopscotch (hop), and
Stat92E encode proteins that are simi-
lar to the mammalian interleukin
receptor, JAK, and STAT, respectively
(Perrimon and Mahowald, 1986;
Binari and Perrimon, 1994; Yan et al.,
1996; Brown et al., 2001). Unlike that
observed in mammals, no other sub-
types of these components have been
identiﬁed in Drosophila. Therefore,
the JAK/STATsignaling in Drosophila
is induced by means of the binding of
Upd family ligands to Dome, which
activates the JAK/STAT signaling cas-
cade (Fig.1).
THE JAK/STAT PATHWAY
AND DROSOPHIAL EYE
DEVELOPMENT
Drosophila Eye
Development
The Drosophila eye has been used
extensively as a model system to
study the functions of signal path-
ways during development. The adult
compound eye is derived from the
eye-antennal imaginal disc of larvae
(Ready et al., 1976). During the larval
stage, the growth and morphogenesis
of the eye disc depend on the Notch-
mediated dorsal–ventral (DV) organ-
izer, the signaling center (Dominguez
and de Celis, 1998; Papayannopoulos
et al., 1998). The organizer, which is
established at the second instar larval
stage, promotes global eye prolifera-
tion and patterning (Go et al., 1998;
Kurata et al., 2000).
In the early third instar eye disc, a
wavelike manner termed the morpho-
genetic furrow(MF)arises attheposte-
rior margin and progresses toward the
anterior margin duringthe thirdinstar
larval stage (Wolff and Ready, 1991).
The MF initiation and progression
require a complex interplay of many
signal pathways, such as Decapenta-
plegic (Dpp), Hedgehog (Hh), Notch,
and Wingless (Wg) signal pathways
(Heberlein et al., 1993; Ma et al., 1993;
Treisman and Rubin, 1995; Heslip
et al., 1997; Greenwood and Struhl,
1999; Baonza and Freeman, 2001; Fu
and Baker, 2003). In the third instar
eye disc, the cells before the MF con-
tinue to proliferate, whereas the cells
behind the MF begin to differentiate
into mature photoreceptors (Wolff and
Ready, 1991). The adult compound eye
is composed of approximately 800
ommatidia. Each ommatidium is com-
posed of eight photoreceptor cells
(Ready et al., 1976). The arrangement
ofthephotoreceptorsindorsalandven-
tral ommatidia display the mirror-
image symmetry along the DV midline,
which is termed ommatidial polarity
(ChanutandHeberlein,1995).
Requirement for the JAK/
STAT Pathway in Eye
Development
Small eyes are observed in the hypo-
morphic upd loss-of-function mutant,
Fig. 1. Schematic diagram of the JAK/STAT pathway in Drosophila. The basic components of
the JAK/STAT pathway include the secreted ligand Unpaired (Upd), the transmembrane receptor
Domeless (Dome), the JAK Hopscotch (Hop), and the transcription factor STAT92E. The pathway
is regulated by multiple signal pathways, chromatin modification, and other regulators. Please
refer to the text for details.
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JAK/STAT PATHWAY IN ORGANO- AND TUMORIGENESIS 2523os
1 (Betz et al., 2001; Chao et al.,
2004). The phenotype of os
1 is
enhanced in the genetic background
of the hop and Stat92E mutants and
is suppressed by overexpression of
hop
Tumorous-lethal, hop
tum-l (Luo et al.,
1999; Tsai and Sun, 2004), which enc-
odes the constitutively active form of
Hop (Hanratty and Dearolf, 1993;
Luo et al., 1995). Down-regulation of
JAK/STAT signaling by means of
overexpression of the dominant-nega-
tive dome
DCYT (Brown et al., 2001) in
the eye ﬁeld reduces eye size (Tsai
and Sun, 2004; Karsten et al., 2006).
Consistently, the up-regulation of
JAK/STAT signaling by overexpres-
sion of upd and hop causes enlarge-
ment of the eyes (Bach et al., 2003;
Tsai and Sun, 2004). In addition, a
growth disadvantage and defects in
ommatidial polarity were found in
both hop and Stat92E mutant clones
(Luo et al., 1999; Zeidler et al., 1999).
Thus, the JAK/STAT pathway is
required for normal eye development.
Activation of the JAK/STAT
Pathway During Eye
Development
The JAK/STAT pathway is activated in
eye tissues during development (Zei-
dler et al., 1999; Tsai and Sun, 2004),
and this activation is dependent on the
presenceof theligandUpd.Theexpres-
sion of Upd is temporally and spatially
regulated during eye development. In
the ﬁrst and early second instar eye
discs, upd is expressed in the ventral
eye (Reynolds-Kenneally and Mlodzik,
2005; Gutierrez-Avino et al., 2009). At
the late second to early third instar
stage, upd is expressed at the posterior
boundary of the DV midline, which is
termed the posterior center (PC). After
MF initiation, upd expression at the
PC is turned off (Zeidler et al., 1999;
TsaiandSun,2004;Fig.2).
The 10XStat92E-GFP reporter has
been used to reﬂect JAK/STAT activity
(Bach et al., 2007), and it has been
revealed that, during the ﬁrst to early
second instar larval stages, the JAK/
STAT pathway is activated at the ven-
tral eye disc, slightly broader than the
region of Upd expression (Gutierrez-
Avino et al., 2009). During the second
to early third instar larval stages, the
pathway is activated in the entire eye
disc (Bach et al., 2007). Of interest,
this activation progressively decreas-
es, depending on the distance from the
PC, where Upd is expressed. It is note-
worthy that the regions of the JAK/
STAT activity are consistent with the
dynamic expression and the secretion
of Upd. In late third instar eye discs,
the JAK/STAT pathway is no longer
active (Zeidler et al., 1999; Tsai and
Sun, 2004; Bach et al., 2007).
Although Upd2 and Upd3 are
reported as ligands for the JAK/STAT
pathway (Agaisse et al., 2003; Gilbert
et al., 2005; Hombria et al., 2005),
whether they play a role in eye devel-
opment remains unknown.
THE FUNCTIONS OF THE
JAK/STAT PATHWAY IN EYE
DEVELOPMENT
Organizer Establishment
The JAK/STAT pathway displays dif-
ferent functions at different stages
during eye development (Fig. 2). The
Notch-mediated DV organizer is
established during the early second
instar larval stage (Dominguez and
de Celis, 1998; Papayannopoulos
et al., 1998) by means of the asym-
metric distribution of the dorsal-com-
partment selector genes of the Iro-
quois complex (Iro-C; McNeill et al.,
1997; Cavodeassi et al., 1999). The
JAK/STAT pathway is activated in
the ventral eye disc at the ﬁrst to
early second instar larval stage (Rey-
nolds-Kenneally and Mlodzik, 2005;
Gutierrez-Avino et al., 2009). Over-
expression of upd at the early stage
results in dorsal eye overgrowth
(Bach et al., 2003). Gutierrez-Avino
et al. indicated that the overgrowth is
associated with ectopic organizer for-
mation (Gutierrez-Avino et al., 2009),
which results from the repression on
Iro-C distribution by the early activity
of Upd. Inhibition of the JAK/STAT
Fig. 2. Functions of the JAK/STAT pathway in Drosophila eye development. The JAK/STAT pathway plays various roles during eye development.
This schematic diagram shows the eye disc at different larval stages and the corresponding functions of the JAK/STAT pathway. Details are
described in the text. The eye-antennal discs are drawn with anterior to the left and dorsal to the top. Light green, Iro-C expression; Pink, upd
expression; yellow lines, dorsal–ventral midline; light blue, Notch/Eyg signaling; dark green, wg expression; gray lines, morphogenetic furrow (MF);
gray arrow, MF progression; black and red arrow, ommatidial polarity.
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2524 WANG AND HUANGsignaling also disturbed the Iro-C
expression at DV, suggesting that the
quantity of JAK/STAT activity is
important for normal Iro-C distribu-
tion and organizer establishment.
Furthermore, epistatic analyses have
demonstrated that JAK/STAT signal-
ing induces growth upstream from
the Notch-mediated DV organizer
(Gutierrez-Avino et al., 2009). Hence,
the JAK/STAT pathway activated in
the ventral eye disc at the early stage
acts upstream from the Iro-C and
Notch signaling to regulate organizer
establishment.
Proliferation
Hyperactivation of the JAK/STAT sig-
naling causes the large-eye phenotype
(Bach et al., 2003; Tsai and Sun, 2004).
Of interest, when upd is clonally over-
expressed in the eye disc, nonautono-
mous cell proliferation is detected only
in the areas anterior to the MF (Tsai
and Sun, 2004). Generating dome
DCYT
overexpression clones reduces the
number of proliferating cells before
the MF (Tsai and Sun, 2004). These
ﬁndings suggest that JAK/STAT sig-
naling can promote proliferation of
cells anterior totheMF.
Notch/Eyegone (Notch/Eyg) signal-
ing is activated exclusively at the DV
boundary but can promote whole-eye
growth at the second instar larval
stage (Dominguez and de Celis, 1998;
Papayannopoulos et al., 1998), sug-
gesting the existence of a mediator
that promotes the global growth.
Indeed, transcription of upd is induced
at PC by Notch/Eyg signaling (this will
be discussed later). Overexpression of
upd by dpp-GAL4 (Staehling-Hamp-
ton et al., 1994) rescues the ‘‘eye
absent’’ phenotype of the eyg mutant,
and the os
1 mutant suppresses the
large-eye phenotype caused by overex-
pression of eyg (Chao et al., 2004).
Thus, Chao et al. concluded that the
JAK/STAT pathway promotes cell pro-
liferation and mediates Notch/Eyg-
induced eye growth at the second
instar larval stage.
MF Initiation and Eye
Speciﬁcity
Wg is homologous to mammalian Wnt
protein. During Drosophila eye devel-
opment, the Wg pathway functions in
specifying head capsule development
(Royet and Finkelstein, 1996) and as
a negative regulator of MF progres-
sion (Ma and Moses, 1995; Baonza
and Freeman, 2002). Of interest, the
generation of Stat92E mutant clones
at the larval stage leads to the forma-
tion of ectopic cuticle or ambiguous
structures in adult eyes (Ekas et al.,
2006). Furthermore, MF initiation is
suppressed when the JAK/STAT path-
way is down-regulated (Tsai et al.,
2007). The upd overexpression clone
induces ectopic MF initiation and
suppresses wg expression. The ectopic
MF initiation can be suppressed when
wg is replenished. These observations
raise the possibility that the JAK/
STAT pathway positively regulates
eye speciﬁcity and MF progression by
means of the repression of wg.
Indeed, there are evidences that
Stat92E and hop mutants exhibit
ectopic wg expression in the eye discs,
and endogenous wg expression is
repressed in the hop overexpression
clone (Ekas et al., 2006; Tsai et al.,
2007). However, wg eye enhancers are
devoid of any STAT92E binding site,
suggesting that STAT92E may not
directly regulate wg (Hou et al., 1996;
Ekas et al., 2006; Tsai et al., 2007).
Therefore, the JAK/STAT pathway
represses the transcription of wg pos-
sibly by means of an indirect mecha-
nism to initiate MF progression and
to determine eye speciﬁcity.
Ommatidial Polarity
The previous studies demonstrated
that the ommatidial polarity is altered
when JAK/STAT activity is misregu-
lated (Luo et al., 1999; Zeidler et al.,
1999). For instance, induction of hop
mutant clones and upd overexpres-
sion clones during early eye develop-
ment results in inversions of ommati-
dial orientation. These ﬁndings
suggest that the JAK/STAT pathway
is involved in the determination of
polarity. However, at the third in-
star larval stage, when ommatidial
polarity begins to be established, the
JAK/STAT signaling observed by
10XStat92E-GFP is no longer acti-
vated (Tsai and Sun, 2004; Bach et al.,
2007). How does the JAK/STAT path-
way control ommatidial polarity?
Because the formation of the DV mid-
line, which decides the ommatidial
polarity (McNeill et al., 1997; Domi-
nguez and de Celis, 1998), requires
JAK/STAT signaling during early eye
development (Flaherty et al., 2009;
Gutierrez-Avino et al., 2009), the early
JAK/STAT signaling may indirectly
contribute to ommatidial polarity by
means of regulating the establish-
ment of the DV midline (Gutierrez-
Avino et al., 2009). Alternatively, JAK/
STAT signaling may regulate ommati-
dial polarity through a noncanonical
mechanism, which is independent of
the STAT92E transactivation activity
(Shi et al., 2006, 2008b).
REGULATION OF THE JAK/
STAT PATHWAY BY SIGNAL
PATHWAYS
The next subject is an explanation of
how the JAK/STAT pathway is regu-
lated during eye development. Signal
pathways always interact with each
other as a network. Some signal path-
ways regulating the JAK/STAT path-
way have been reported, including
the Hh, Notch, and target of rapamy-
cin (TOR) pathways. Besides, the
JAK/STAT pathway performs a feed-
back loop to regulate itself (Fig. 1).
Hh Pathway
The hh gene is expressed in the ven-
tral eye disc during the ﬁrst instar
stage but is expressed in the entire
posterior margin from the late second
to third instar stage (Cho et al., 2000).
This dynamic expression resembles
that of upd, with the exception that
upd is expressed speciﬁcally at the PC
but not in the entire posterior margin
at the third instar stage, which sug-
gests a correlation between these two
pathways. The Hh pathway is acti-
vated as Hh binds to, and inhibits,
Patched (Ptc), allowing the trans-
membrane protein Smoothened to
activate the downstream transcrip-
tion factor Cubitus interruptus (Ci;
Ingham and McMahon, 2001). upd
ectopic expression can be induced
when ptc mutant clones are generated
at the lateral margin or DV boundary,
suggesting that the Hh signaling
induces upd expression. However, the
ptc mutant clones that do not reside at
the lateral margin or at the DV boun-
dary are unable to induce upd ex-
pression (Reifegerste et al., 1997),
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JAK/STAT PATHWAY IN ORGANO- AND TUMORIGENESIS 2525indicating that other factors are
involved in the regulation of upd
expression.
Notch Pathway
The Upd expression at the PC raises
the possibility that the signal at the
DV midline may regulate upd tran-
scription positively. Notch signaling is
activated and turns on eyg transcrip-
tion at the DV midline in the second
instar eye disc (Dominguez and de
Celis, 1998; Papayannopoulos et al.,
1998; Agaisse et al., 2003; Jang et al.,
2003; Chao et al., 2004; Dominguez
et al., 2004). Previous reports demon-
strated that upd transcription is
inhibited in Notch mutant clones and
dominant-negative Notch-expressing
clones, and that the loss of eyg also
results in the down-regulation of upd
transcription at the PC (Chao et al.,
2004; Reynolds-Kenneally and Mlod-
zik, 2005). This suggests that the
Notch/Eyg pathway acts upstream of
the JAK/STAT pathway to activate
the upd expression at the PC.
Conversely, recent reports found
that regulation of the JAK/STAT
pathway upstream from the Notch
pathway (Flaherty et al., 2009;
Gutierrez-Avino et al., 2009). Serrate
(Ser), which encodes a Notch ligand,
is speciﬁcally expressed in the ventral
eye disc (Papayannopoulos et al.,
1998). Its transcription in the eye disc
is repressed upon Upd overexpression
(Flaherty et al., 2009). Additionally,
the transcription of Ser is induced in
Stat92E mutant clones, and it accom-
panies ectopic activation of Notch/Eyg
signaling at the dorsal area. This evi-
dence indicates that the down-regula-
tion of the JAK/STAT pathway leads
to derepression of Ser in the dorsal
eye and results in ectopic Notch/Eyg
activity. Furthermore, the eye reduc-
tion observed in ﬂies with down-regu-
lation of the JAK/STAT pathway
could be restored by overexpression of
Notch intracellular domain. Upd over-
expression by eyeless-GAL4 (Hauck
et al., 1999) cannot promote eye over-
growth in the eyg mutant background
(Gutierrez-Avino et al., 2009). The
epistatic analyses demonstrated that
the JAK/STAT pathway possibly indu-
ces growth upstream from the Notch/
Eyg pathway.
Taken together, these ﬁndings sug-
gest that the activation of JAK/STAT
pathway is regulated by Notch/Eyg
signaling. However, because the JAK/
STAT pathway also exhibits an ability
to act upstream from Notch/Eyg sig-
naling, how the interplay between the
JAK/STAT and Notch pathways is
controlled during eye development
needs further investigation.
TOR Pathway
The TOR pathway is required for the
growth of the Drosophila eye (Oldham
and Hafen, 2003). The proline-rich
Akt substrate of 40 kDa (PRAS40)
regulates the mammalian TOR path-
way (Fonseca et al., 2007; Sancak
et al., 2007; Vander Haar et al., 2007).
After a decrease in the expression of
the Drosophila PRAS40 homolog,
Lobe, in the eye disc, TOR signaling is
down-regulated and upd is ectopically
expressed (Wang and Huang, 2009).
In Lobe mutants, Notch/Eyg signaling
is not hyperactivated, and the expres-
sion of Ci, Hh downstream transcrip-
tion factor, is not associated with the
ectopic upd expression, suggesting
that TOR signaling may regulate the
JAK/STAT pathway independently of
the Hh and Notch/Eyg pathways.
Overexpression of the Drosophila
TOR (dTOR), which is the major fac-
tor in the TOR pathway, also results
in hypoactivation of the TOR pathway
(Hennig and Neufeld, 2002) and
ectopic upd expression (Wang and
Huang, 2009). Furthermore, JAK/
STAT activity is elevated in dTOR
overexpression clones (unpublished
data by Wang and Huang). These
data indicate that the TOR pathway
acts upstream of the JAK/STAT path-
way by means of the repression of
upd expression.
JAK/STAT Pathway
In addition to other signaling path-
ways, the JAK/STAT pathway may
regulate itself by means of the induc-
tion of the transcription of dome. The
dome gene is a transcriptional target
of the JAK/STAT pathway (Ghiglione
et al., 2002) and is up-regulated after
upd overexpression in the eye (Flah-
erty et al., 2009). As Dome is the recep-
tor of the JAK/STAT pathway, it is
reasonable that overexpression of
the Dome dominant-negative form
dome
DCYT causes eye reduction. How-
ever, overexpression of full-length
Dome is unable to suppress the
reduced-eye phenotype of upd
mutants. Indeed, it renders wild-type
eyes smaller (Bach et al., 2003). There-
fore,theJAK/STATpathwayregulates
its own activity by means of regula-
tion of dome transcription; however,
whether Dome negatively regulates
the JAK/STAT signaling pathway
needsfurther investigation.
OTHER MECHANISMS
REGULATING THE JAK/STAT
PATHWAY
In addition to the signaling network
described above, many regulators of
the JAK/STAT pathway, such as
SOCS36E, dPIAS, and dBRWD3,
have been found in the last decade.
Moreover, endosomal transport and
epigenetic mechanisms also govern
the pathway (Fig. 1).
SOCS36E
The Drosophila SOCS36E is homolo-
gous to the mammalian suppressor of
cytokine signaling (SOCS; Karsten
et al., 2002), which is activated by the
JAK/STAT pathway and suppresses
JAK/STAT through a negative-feed-
back loop (Kile and Alexander, 2001;
Krebs and Hilton, 2001). SOCS36E is
expressed in eye discs. It is ectopically
expressed after upd overexpression
and has been validated as a target
gene of Stat92E (Karsten et al., 2002;
Bach et al., 2007). Overexpression of
SOCS36E exacerbates the eye-reduc-
tion phenotype of upd mutants, sug-
gesting that SOCS36E may repress
JAK/STAT signaling. However, over-
expression of SOCS36E in wild-type
ﬂies does not reduce eye size (Bach
et al., 2003). The SOCS36E mutant
identiﬁed recently (Almudi et al.,
2009) could be used to determine
whether the JAK/STAT pathway
requires SOCS36E-mediated negative
regulation during eye development.
dPIAS
The Drosophila protein inhibitor of
activated STAT (dPIAS) is homolo-
gous to the mammalian PIAS proteins
(Hari et al., 2001), which inhibit
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2526 WANG AND HUANGSTAT signaling by promoting STAT
degradation (Chung et al., 1997; Liu
et al., 1998; Ungureanu et al., 2003).
Overexpression of dPIAS decreases
eye size, and down-regulation of
dPIAS partially suppresses the small-
eye phenotype of the upd loss-of-func-
tion mutant, os
1, suggesting that
dPIAS is a negative regulator of the
JAK/STAT signaling pathway (Betz
et al., 2001). However, complete loss
of dPIAS does not produce the
enlarged-eye phenotype that occurs
after hyperactivation of the JAK/
STAT pathway. Whether the ability of
dPIAS to repress JAK/STAT signaling
is required for eye development
remains uncertain.
Endosomal Trafﬁc
Precise regulation of the trafﬁcking of
ligands and receptors is critical for sig-
nal pathway transduction. It was pre-
viously shown that defects in endoso-
mal trafﬁc affect the JAK/STAT
pathway (Moberg et al., 2005; Thomp-
son et al., 2005; Vaccari and Bilder,
2005). Endosomal sorting complex
required for transport (ESCRT) pro-
tein complexes function in sorting pro-
teins to lysosome for degradation
(Bishop and Woodman, 2001; Babst
et al., 2002). In the Drosophila eye, the
loss of ESCRT components, such as
Vacuolar protein sorting 25 (Vps25, a
component of ESCRT-II) and Erupted
(Ept, the vps23 homolog encoding a
component of ESCRT-I), causes large-
eye phenotype (Moberg et al., 2005;
Vaccari andBilder,2005). Whenclones
of ept or vps25 were generated in the
eye disc, nonautonomous cell prolifer-
ation and elevated JAK/STAT activity
were detected (Moberg et al., 2005;
Thompson et al., 2005; Vaccari and
Bilder, 2005; Gilbert et al., 2009).
Blocking JAK/STATsignaling can sup-
press the overgrowth phenotype, sug-
gesting that the proliferation is medi-
ated by means of the JAK/STAT
pathway (Moberg et al., 2005; Thomp-
son et al., 2005; Gilbert et al., 2009).
Because ectopic upd expression and
Notch accumulation are detected in
both ept and vps25 clones, it is reason-
able to assume that the elevated JAK/
STAT signaling is caused by the
Notch-induced upd expression. Fur-
thermore, Dome accumulation was
detected in ept mutant clones (Moberg
et al., 2005; Gilbert et al., 2009).
Because Upd can increase the endo-
cytic uptake of Dome (Ghiglione et al.,
2002) and the elevated JAK/STAT sig-
naling promotes dome transcription
(Bach et al., 2003), the excessive Dome
accumulation may be the consequence
of hyperactivated JAK/STAT signal-
ing. Alternatively, the endocytic con-
trol of Dome trafﬁcking is critical for
the activation of JAK/STAT signaling
(Devergne et al., 2007). Dome accumu-
lation may result from a defect in Ept-
mediated endocytic transport and may
lead to JAK/STAT hyperactivation.
Taken together, these data indicate
that precise endosomal transport is
important for regulating the activa-
tionof the JAK/STAT pathway.
Epigenetic Mechanisms
Multiple chromatin factors are regu-
lators of the Drosophila JAK/STAT
pathway (Brown and Zeidler, 2008),
indicating that the pathway is regu-
lated through epigenetic mechanisms.
We focus on the factors that regulate
the pathway in the eye.
dBRWD3
The Drosophila BRWD3 (dBRWD3)
gene encodes the bromodomain- and
WD40-containing protein (D’Costa
et al., 2006). A genome-wide RNA
interference screen using Drosophila
cells revealed that dBRWD3 is a posi-
tive regulator of the JAK/STAT path-
way (Muller et al., 2005). The ﬂy deﬁ-
ciency line uncovering dBRWD3
(Bach et al., 2003) and the hetero-
zygosity of the dBRWD3 mutant
(Muller et al., 2005) suppress the eye-
enlargement phenotype caused by
upd overexpression, suggesting that
dBRWD3 is required in the JAK/
STAT pathway. dBRWD3 is a chroma-
tin-associated protein (D’Costa et al.,
2006). The human BRWD3 homolog,
BRWD1, is associated with the chro-
matin-remodeling complex (Ramos
et al., 2002; Huang et al., 2003). It is
possible that dBRWD3 regulates the
JAK/STAT pathway by means of chro-
matin remodeling.
Heterochromatin Protein 1
The Drosophila JAK/STAT pathway
has the noncanonical function in regu-
lating heterochromatin stability (Shi
et al., 2006, 2008b). Unphosphory-
lated STAT92E acts to stabilize
heterochromatin by binding the heter-
ochromatin component, hetero-chro-
matin protein 1 (HP1). Activation of
the JAK/STAT pathway results in
STAT92E phosphorylation, which
reduces STAT92E and thus HP1 in
heterochromatin, causing global het-
erochromatin instability. The large-
eye phenotype caused by upd overex-
pression is enhanced by lowering the
dosage of HP1 and is suppressed by
overexpression of HP1 (Shi et al.,
2006), suggesting that global hetero-
chromatin status regulates the func-
tion of the hyperactivation of JAK/
STAT pathway.
Polycomb group
The polycomb group (PcG) genes
encode proteins involved in epigenetic
gene silencing (Schwartz and Pir-
rotta, 2007). upd transcription and
STAT92E activity are up-regulated in
PcG mutant eye discs, which exhibit
strong overgrowth (Classen et al.,
2009). Interference with the JAK/
STAT signaling ameliorates the over-
growth phenotype. In addition, upd is
a direct target of PcG-mediated gene
silencing in Drosophila eye discs
(Classen et al., 2009). PcG has also
been shown to repress directly the
transcription of Notch and eyg (Marti-
nez et al., 2009), which are required
for the upd expression at the PC
(Chao et al., 2004; Reynolds-Ken-
neally and Mlodzik, 2005). Thus, PcG
regulates upd expression in both
direct and indirect ways. These data
indicate that upd transcription is con-
trolled by a PcG-mediated chromatin
modiﬁcation.
FUNCTIONAL SWITCHES OF
THE JAK/STAT PATHWAY
The Drosophila JAK/STAT pathway
performs diverse functions that are
dependent on the developmental tim-
ing and the genetic backgrounds.
Developmental Timing
A functional switch of the Drosophila
JAK/STAT pathway during develop-
ment was originally found in the
wing disc (Mukherjee et al., 2005).
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tion at the early stage but represses
proliferation at the late stage. An
unidentiﬁed noncanonical JAK/STAT
pathway, which is not activated by
Upd and Hop, accounts for the anti-
proliferative role. Activating the can-
onical JAK/STAT pathway by overex-
pression of Upd or Hop can also
reduce proliferation at the late stage
(Mukherjee et al., 2005). The data
indicate that the opposite functions of
the JAK/STAT pathway appear in dif-
ferent developmental timing.
Similarly, in the eye disc, the
expression of Ser that encodes a
ligand of Notch is suppressed by over-
expression of Upd by GMR-GAL4
(Flaherty et al., 2009) but is ectopi-
cally induced by overexpression of
Upd by eyeless-GAL4 (Gutierrez-
Avino et al., 2009). The opposite
effects on the Ser expression may be
attributed to the different timing of
the overexpression, in which GMR-
GAL4 drives gene expression in cells
posterior to the MF from the third
instar larval stage (Hay et al., 1994);
however, eyeless-GAL4 drives gene
expression in the embryonic eye pri-
mordium and in undifferentiated cells
of larval eye discs (Hauck et al.,
1999). The data suggest that the JAK/
STAT pathway is positively and nega-
tively regulated by Notch signaling at
the early and late stages, respectively
(Flaherty et al., 2009; Gutierrez-
Avino et al., 2009).
Genetic Backgrounds
The function of the JAK/STAT path-
way in Drosophila also varies accord-
ing to the genetic background. Some
reports have shown that the JAK/
STAT pathway has speciﬁc functions
only in the absence of speciﬁc cellular
factors.
ept Mutant
Crumbs (Crb) is an epithelial polarity
factor (Tepass et al., 1990). Excess
production of Crb, which is always
observed in neoplastic tissues, dis-
rupts the architecture and polarity of
epithelial tissues (Klebes and Knust,
2000; Sotillos et al., 2004). The JAK/
STAT pathway is required for the crb
expression in ovarian follicle cells and
the posterior spiracles (Ghiglione
et al., 2002; Lovegrove et al., 2006).
However, the regulation is not seen in
the wild-type eye disc because the
level of the Crb protein is not altered
in Stat92E mutant clones of the eye
disc (Gilbert et al., 2009). Intrigu-
ingly, the ept mutant cells in eye discs
display up-regulation of the JAK/
STAT signaling, and the accumulation
of Crb protein has been detected
(Moberg et al., 2005; Gilbert et al.,
2009). The mRNA level of crb was ele-
vated in the ept mutant eye disc, but
this elevation was suppressed by loss
of one copy of Stat92E (Gilbert et al.,
2009). This suggests that the hyperac-
tivated JAK/STAT pathway is respon-
sible for the up-regulation of crb
expression in the ept mutant. Because
Ept functions in endocytic transport,
these ﬁndings indicate that disrup-
tion of endosomal trafﬁc allows the
JAK/STAT pathway in the eye disc to
adopt the ability to regulate the crb
expression.
Lobe Mutant
The small-eye phenotype of os
1 is not
suppressed by a reduction of apopto-
sis (Tsai and Sun, 2004). Additionally,
a reduction of apoptosis does not
affect the eye enlargement caused by
upd overexpression (Bach et al.,
2003). These ﬁndings indicate that
the JAK/STAT pathway does not
affect apoptosis in the eye disc. How-
ever, in Lobe mutants, cell apoptosis
and ectopic JAK/STAT activation
were observed, and they acted
together to yield the small-eye pheno-
type (Wang and Huang, 2009). A
decrease in JAK/STAT activity sup-
presses the apoptosis and the small-
eye phenotype, suggesting that this
pathway plays a role in promoting
apoptosis (Wang and Huang, 2009).
In other words, the JAK/STAT path-
way exhibits a novel function, i.e., the
promotion of cell apoptosis, in the
Lobe mutant but not in a wild-type
genetic background.
CONSERVATION OF THE
JAK/STAT PATHWAY
The JAK/STAT Pathway in
Tumorigenesis
The mutant of hop
Tum-l, which encodes
a hyperactivated JAK that overacti-
vates STAT92E, has leukemia-like
hematopoietic tumors (Hanratty and
Dearolf, 1993; Harrison et al., 1995;
Luo et al., 1995; Hou et al., 1996; Yan
et al., 1996; Muller et al., 2005). In the
Drosophila eye, overexpression of Upd
causes hyperactivation of the JAK/
STAT pathway, which increases the
number of mitotic cells and increases
eye size (Bach et al., 2003; Tsai and
Sun, 2004). The hyperactivated JAK/
STAT pathway caused by the loss of
the tumor suppressor genes, such as
vps25 (Thompson et al., 2005) and PcG
(Sparmann and van Lohuizen, 2006;
Martinez et al., 2009), is responsible
for the neoplastic phenotype in eye tis-
sue (Vaccari and Bilder, 2005; Classen
et al., 2009). Thus, the hyperactivated
JAK/STAT pathway exhibits a pro-
growth function and leads to tumor
formationin Drosophila.
Aberrant activation of the JAK/
STAT pathway causes pro-growth in
humantumors (Caloetal.,2003;Smir-
nova et al., 2007; Constantinescu
et al., 2008). Overexpression of consti-
tutively active STAT3 in nude mice
results in the formation of tumors
(Bromberg et al., 1999), and the con-
stitutive activation of several subtypes
of STATs has been reported in many
human tumors, including blood and
solid cancers (Calo et al., 2003; Smir-
nova et al., 2007). Hyperactive and
constitutive forms of JAK mutations
have been identiﬁed in human hema-
topoietic malignancies (Constanti-
nescu et al., 2008). The data indicate
that the pro-growth function of the
hyperactivated JAK/STAT pathway is
conserved and is a link to the human
tumorigenesis.
The mechanism by which the
hyperactivated JAK/STAT pathway
performs the pro-growth function is
not clear. In human cancers, the
mammalian STAT proteins activate
the genes promoting cell cycle pro-
gression, such as cyclin D1 and c-myc,
and the genes inhibiting apoptosis,
such as bcl-x (Calo et al., 2003). Fur-
thermore, it has been assumed that
the hyperactivated JAK/STAT path-
way acts through these effecters to
promote cancer formation. In the
Drosophila eye, overexpression of upd
induces ectopic expression of Cyclin D
(Bach et al., 2003; Tsai and Sun,
2004), suggesting that Cyclin D is a
possible mediator for the pro-growth
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2528 WANG AND HUANGfunction of the JAK/STAT pathway.
However, the large-eye phenotype
caused by overexpression of upd is
not suppressed by the loss of one copy
of cyclin D or another core cell cycle
regulatory protein (Mukherjee et al.,
2006), indicating that cell cycle regu-
lators may be not the major effecters.
Finding the factor mediating the pro-
growth function of the hyperactivated
Drosophila JAK/STAT pathway may
help us understand the mechanism of
JAK/STAT-mediated tumorigenesis.
Functional Switches of the
JAK/STAT Pathway
Functional switches of the JAK/STAT
pathway are also found in mammals.
The mammalian JAK/STAT pathway
can act differently depending on the
developmental stages. For instance,
the differentiation of astrocytes in the
developing brain requires JAK/STAT
signaling. However, ectopic induction
of JAK/STAT signaling is able to trig-
ger the downstream target of STAT3
only at the late stage, but not at the
early stage (Takizawa et al., 2001),
which indicates that the function of
the JAK/STAT pathway is dependent
on developmental timing.
Furthermore, the function of the
mammalian JAK/STAT pathway also
varies according to the genetic back-
ground. The mammalian STAT3 is
generally considered a pro-growth
factor, which promotes proliferation
and prevents apoptosis (Stephanou
and Latchman, 2005). In contrast, in
the absence of SOCS3 in murine
embryonic ﬁbroblasts, which causes
hyperactivation of STAT3 and dysre-
gulates the STAT3 target gene expres-
sion, STAT3 becomes apoptotic (Lu
et al., 2006). In glioblastoma, STAT3
can have opposite functions depend-
ing on the genetic background; STAT3
is tumor suppressive in the absence of
the tumor suppressor PTEN but is
oncogenic upon expression of the
oncogenic form of the epidermal
growth factor receptor EGFRvIII (de
la Iglesia et al., 2008). Additionally,
STAT1 acts to prevent proliferation
and promote apoptosis (Stephanou
and Latchman, 2005), but in some
tumor cells, STAT1 plays a prosur-
vival role (Patterson et al., 2006; Tim-
ofeeva et al., 2006).
The Drosophila JAK/STAT pathway
displays pro- and anti-proliferative
functions at different times during
wing development (Mukherjee et al.,
2005), and this behavior resembles
the general function of mammalian
STAT3 and STAT1 (Bowman et al.,
2000; Stephanou and Latchman,
2005). This may reﬂect the evolution-
ary event that the distinct functions of
STAT92E are subsequently assigned
to distinct vertebrate STAT proteins
(Mukherjee et al., 2005). However,
because having diverse functions in
different statuses is found in both Dro-
sophila and mammalian JAK/STAT
pathways, the phenomena may point
to a common property, in which the
JAK/STAT pathway can act differently
when genetic background and devel-
opmentaltiming are changed.
FUNCTIONAL DECISIONS
OF THE JAK/STAT PATHWAY
How does the JAK/STAT pathway
play distinct roles at different devel-
opmental times and genetic back-
grounds? In the case of astrocyte dif-
ferentiation, STAT3 directly binds
and activates the gene gfap, which
encodes the astrocyte marker glial
ﬁbrillary acidic protein (GFAP; Bonni
et al., 1997; Song and Ghosh, 2004).
The accessibility of STAT3 in the gfap
promoter is regulated by the develop-
mental stage-dependent DNA methyl-
ation (Takizawa et al., 2001), ﬁbro-
blast growth factor 2-dependent
histone methylation (Song and
Ghosh, 2004), and retinoic acid-
dependent histone H3 acetylation
(Asano et al., 2009). The evidence
indicates that, during development,
chromatin structures controlled by
signaling pathways determine the
function of the JAK/STAT pathway.
The aforementioned ﬁndings show
that Notch, Hh, and TOR signal path-
ways can regulate the JAK/STAT
pathway; however, the detail of the
mechanism is still unclear. Mamma-
lian Notch intracellular domain has
functional interaction with histone
acetylases and assists in chromatin
remodeling (Kurooka and Honjo,
2000). It is possible that these signal
pathways regulate the JAK/STAT
pathway by means of epigenetic mech-
anisms. Additionally, it is known that
PcG can directly suppress upd and
Notch transcription, indicating that
an epigenetic mechanism can regulate
JAK/STAT activation directly or
throughothersignal pathways.
On the other hand, the JAK/STAT
pathway can act conversely to regu-
late other signaling pathways, such
as Notch and Wg (Ekas et al., 2006;
Tsai et al., 2007; Flaherty et al., 2009;
Gutierrez-Avino et al., 2009), and can
affect global epigenetic status per se.
In Drosophila, constitutive JAK/STAT
signaling disrupts heterochromatin
structures and affects the genes that
are not the direct target of STAT (Shi
et al., 2006). Mammalian STAT pro-
teins recruit chromatin-modifying
enzymes such as histone acetyltrans-
ferases (Schindler et al., 2007). Acti-
vation of the mammalian JAK/STAT
pathway can trigger chromatin
remodeling (Christova et al., 2007;
Shi et al., 2008a).
These ﬁndings lead to a model in
which the JAK/STAT pathway, epige-
netic status, and other signal path-
ways are regulated by each other in
an interdependent network (Fig. 3).
During normal development, the
JAK/STAT pathway is activated by
signaling pathways and epigenetic
mechanisms, both of which coopera-
tively determine the function of the
JAK/STAT pathway. After being acti-
vated, the JAK/STAT signaling con-
versely alters the other signaling
pathways and chromatin structures,
which thus adjust the functions of the
JAK/STAT pathway at later stages.
Finally, the negative factors such as
SOSC36E act together with signaling
pathways and chromatin status,
which suppress upd transcription at
this stage, to turn off the JAK/STAT
signaling. Upon loss of ept or Lobe,
hyperactivated JAK/STAT signaling
and dysregulated Notch or TOR path-
ways disrupt the balance of the net-
work, resulting in aberrant functions
of the JAK/STAT pathway. Therefore,
the interplay among the JAK/STAT
pathway, epigenetic status, and other
signaling pathways controls the
strength, duration, and output of the
JAK/STAT signaling.
FUTURE PERSPECTIVES
Several questions remain unanswered
regarding the functions and regula-
tions of the JAK/STAT pathway. First,
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the JAK/STAT pathway affects normal
eye development by controlling chro-
matin structures. Second, do develop-
mental timing and signal pathways
control the transcription of upd
through epigenetic mechanisms? The
epigenetic status of the upd locus in
different developmental stages and in
the mutation of genes, such as Hh,
Notch, ept,vps25,andLobe,whichreg-
ulate upd transcription, should be
investigated. It is also interesting to
study whether the other signaling
pathways regulate upd transcription
through PcG.
Next, if the function of the hyperac-
tivated JAK/STAT pathway differs
from that of the endogenous one, the
data of hyperactivated JAK/STAT
signaling should be carefully inter-
preted. For example, whether the fac-
tors modifying the phenotype of hyper-
activated JAK/STAT pathway also
participate in the endogenous pathway
should be conﬁrmed. Whether the pro-
growthfunctionoftheJAK/STATpath-
way is mediated by alteration of epige-
netic status and other signal pathways
awaitsfurtherinvestigation.
Moreover, to investigate whether
the diverse functions of the Droso-
phila JAK/STAT pathway in different
developmental stages and in the
aforementioned conditions are attrib-
uted to epigenetic alteration and dys-
regulation of global gene expressions,
the further examinations, such as
genome-wide analyses of epigenetic
status, transcriptome, and the expres-
sion of the STAT92E target genes, are
required.
The function and regulation of the
JAK/STAT pathway observed in the
Drosophila eye may be evolutionarily
conserved in mammals. For instance,
mammalian interleukins, like the
Upd signal through the JAK/STAT
pathway, are also regulated by the
Notch and the TOR pathways (Amsen
et al., 2004; Weichhart et al., 2008).
In addition, SOCS and PIAS are well-
known modulators of the mammalian
JAK/STAT pathway (Shuai, 2006;
Croker et al., 2008). The signal path-
ways and epigenetic mechanisms reg-
ulating the Drosophila JAK/STAT
pathway have been implicated in
tumorigenesis (Wicking and McGlinn,
2001; Faivre et al., 2006; Leong and
Karsan, 2006; Sparmann and van
Lohuizen, 2006). Furthermore, it has
been proposed that hyperactivation of
the JAK/STAT pathway in cancers
may alter global chromatin conforma-
tion, leading to dysregulation of non-
target genes (Constantinescu et al.,
2008). It is possible that the interplay
among the JAK/STAT pathway, other
signal pathways, and epigenetic sta-
tus (Fig. 3) contributes to the activa-
tion and functions of the JAK/STAT
pathway in human cancers. Thus,
examination of the hypothesis will
provide valuable insights into the
biology of cancer.
Human tumors have genetic hetero-
geneity (Heppner, 1984). The complex
interactions between tumor cells and
the adjacent cells are important for
tumorigenesis (Kinzler and Vogel-
stein, 1996; Hanahan and Weinberg,
2000). The Drosophila eye is a well-
established platform for clonal analy-
ses (Xu and Rubin, 1993; Lee and Luo,
1999), which are used to study the
interactions of the neighboring cells of
different genetic backgrounds. There-
fore, the investigations using the Dro-
sophila eye may provide insights into
the role of the JAK/STAT pathway in
organogenesisand tumorigenesis.
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